• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Nat Rev Microbiol. Author manuscript; available in PMC Oct 20, 2009.
Published in final edited form as:
PMCID: PMC2764292

Architects of Assembly: roles of Flaviviridae nonstructural proteins in virion morphogenesis


Viruses of the Flaviviridae family, including hepatitis C, dengue, and bovine viral diarrhoea, are responsible for significant morbidity and mortality worldwide. Recent advances in understanding virion assembly have uncovered commonalities among distantly related members of this family. We discuss the emerging hypothesis that physical virion components are not alone in forming the infectious particle, but that nonstructural proteins are intimately involved in orchestrating morphogenesis. Pinpointing the roles of Flaviviridae proteins in virion production could reveal new avenues for antiviral therapeutics.


The Flaviviridae family is a group of small, enveloped RNA viruses, consisting of the genera Hepacivirus, Flavivirus, and Pestivirus, and including numerous significant pathogens. Approximately 120 million people worldwide are currently infected with hepatitis C virus (HCV), the prototype member of the Hepacivirus genus. These individuals are at risk of developing cirrhosis, hepatocellular carcinoma and extrahepatic disease. The genus Flavivirus includes vector-borne disease agents such as yellow fever virus (YFV), dengue virus (DEN), and West Nile virus (WNV). Many of these pathogens are resurging and spreading to new environments and are responsible for significant morbidity and mortality. Pestiviruses, including bovine viral diarrhoea virus (BVDV) and classical swine fever virus (CSFV), are pathogens of animals and are of significant financial concern to the livestock industry (reviewed in 1).

The Flaviviridae genome is a single-stranded RNA molecule, which, upon introduction to the cell, is recognized as a messenger RNA and translated by the host cell machinery to yield a polyprotein (Fig 1). Processing by viral and cellular enzymes releases the individual viral gene products (Fig 2). Structural proteins, which comprise the virion, consist of core (capsid in flaviviruses, C) and the envelope glycoproteins. Most of the nonstructural proteins associate to form the replicase complex, which catalyzes RNA accumulation in close association with modified cytoplasmic membranes2,3,4. NS3 and its cofactor NS4A, or NS2B (flaviviruses), is the main viral protease; NS3 also has helicase and nucleoside triphosphatase (NTPase) activities, which are essential for replication. NS5B and NS5 (flaviviruses) constitute the viral RNA-dependent RNA polymerases. NS1, a secreted protein unique to flaviviruses, plays a role early in replication. HCV and pestivirus NS4B and NS5A proteins, as well as flavivirus NS2A, NS4A and NS4B proteins, have as yet undefined but essential roles in RNA accumulation (reviewed in 1).

Fig 1
Life cycle of the Flaviviridae
Fig 2
Processing and putative topologies of the Flaviviridae polyproteins

Many of the features of Flaviviridae replication have been elucidated using viral genomic cDNA clones. Transcription of the genomic RNA in vitro, followed by its transfection into cultured cells is sufficient to launch a full infectious cycle for many flavivirus and pestivirus isolates (see 5, 6 for examples). In contrast, HCV genomes have been extremely difficult to propagate in culture. Emergent mutations and adapted cell lines were able to coax modest levels of RNA replication, but failed to produce progeny virions7,8. In a recent and major advance, a unique patient isolate, termed Japanese fulminant hepatitis 1 (JFH-1) was found to replicate robustly and produce infectious HCV in cell culture9,10,11. This breakthrough has allowed the previously enigmatic processes of HCV assembly, infectivity, and entry to be investigated for the first time.

Production of infectious virus

The enveloped virions of the Flaviviridae are thought to arise by budding of the C protein and associated genomic RNA into endoplasmic reticulum (ER)-derived membranes that are studded with virus envelope glycoproteins (Fig 3). Although morphogenesis is expected to commence by binding of C to RNA, a packaging signal has not been identified for any member of the Flaviviridae. Nucleocapsids are rarely observed in infected cells, and detailed cryo-electron microscopy image reconstructions of members of the genus Flavivirus have indicated that these virions do not contain an ordered nucleoprotein interior12,13,14,15,16. The basic C protein might instead aggregate with the RNA to neutralize and condense it within the particle17,18, forming a complex that does not make contacts with the envelope14. This suggests that the glycoproteins, which form a highly ordered herringbone-like array on the surface of the mature virion12,13, drive morphogenesis through their lateral associations19. Consistent with this, subviral particles that contain no C or RNA, are produced in natural flavivirus infections and can be induced by overexpression of the glycoproteins in cells20. It is not known whether HCV or pestivirus infection also results in subviral particle production.

Fig 3
Proposed pathways of Flaviviridae assembly and egress

After budding, Flaviviridae particles are transported through the cellular secretory pathway to the extracellular milieu. For the genus Flavivirus, egress coincides with a massive, acid-induced, reorganization of the glycoproteins, from trimeric spikes15,21 to an array of dimers that completely cover the lipid bilayer in a relatively smooth proteinaceous coat12,13,22. This conformational change allows cleavage of the prM envelope protein by furin in the trans Golgi network22,23. prM functions to protect the fusogenic E protein during transit through the acidic compartments of the secretory pathway24 and its processing, followed by dissociation of the pr fragment upon particle release22, results in mature virions that are primed for low-pH triggered entry into a naïve target cell24. The maturation of particles of the genera Hepacivirus and Pestivirus seems to be fundamentally different from that of flaviviruses. Intracellular infectious virus can be released from HCV- 25 and pestivirus- 26 infected cells, suggesting that these virions mature immediately or rapidly after their formation; post-assembly cleavage events analogous to flavivirus prM processing do not seem to be involved. Despite undergoing low-pH dependent entry, HCV and BVDV particles are acid resistant, indicating that unknown factors during uptake, rather than during egress, prime the envelope proteins for fusion27,28. Although HCV virions are infectious soon after they are formed, they undergo physical modification during egress, decreasing in density as they pass through the secretory pathway25. The finding that very low-density lipoprotein (VLDL) components form essential interactions with HCV during morphogenesis has led to speculation that HCV particles might be closely associated with, or even internalized in, lipid-rich host structures during virus assembly and secretion29,30,31.

Nonstructural proteins orchestrate assembly

Most nonstructural proteins have essential roles in replication, and it was long thought that these replicase proteins were responsible solely for catalyzing the accumulation of genomic RNA molecules that could subsequently be packaged by the structural proteins. This canonical division of labour was initially supported by the ability of subgenomes that lack the structural region to efficiently undergo RNA synthesis7,8,32,33. Whereas replication is independent of the structural proteins, however, packaging of genomes into infectious particles seems to require more than just the physical components of the virion. This Review examines the emerging hypothesis that many Flaviviridae nonstructural proteins are directly and intimately involved in infectious virion morphogenesis, and might orchestrate this complex process at specialized sites of assembly.

Roles for nonstructural proteins in the production of infectious virus p7 membrane protein

One of the first Flaviviridae nonstructural proteins found to function in infectious virus production was the pestivirus product p7 (Fig 4)34. This small hydrophobic protein, which consists of two membrane-spanning helices and a conserved basic cytosolic loop35,36, has a homologue in the hepacivirus but not the flavivirus genome35,37,38. Deletion of p7 does not affect RNA replication, but completely abrogates the production of infectious pestivirus or HCV particles34,39,40. Incomplete processing of p7 by signal peptidase results in an accumulation of uncleaved E2-p7, an envelope protein precursor that might be incorporated into virions as a minor component36,37,38,41,42. This fusion protein, however, is not essential for BVDV34 or HCV39 infectivity, and neither p7 nor E2-p7 has been detected in pestivirus particles36; studies of HCV virions are ongoing.

Fig 4
Required features of the p7-NS2-3-4A or NS2A-2B-3 polyprotein regions

Similarities have been noted between p7 and viroporins, a class of small, hydrophobic, viral proteins that have ion channel activity in vitro, and are involved in enhancing infectivity (Box 1)34,35,43. HCV and BVDV p7 proteins oligomerize into ion conductive pores in various artificial systems43,44,45,46. Although the stoichiometry and specificity of the channels are not known, it has been proposed that HCV p7 forms hexameric43,47 or heptameric complexes48 with a preference for cation conduction43,48,49. Conserved basic residues within the p7 cytosolic loop are involved in ion channel activity44,48 and were found to be essential for infectious pestivirus production34, required for induction of HCV viraemia in chimpanzees50, and important for optimal growth of HCV in tissue culture39,40. Mutations of residues within the proposed interior of the pore, however, did not drastically affect infectious titres39,40.

Box 1Viroporins

Viroporins are an expanding group of small (60–100 residue) hydrophobic viral proteins that demonstrate oligomerization and membrane permeablization activities in vitro and in cell-based artificial systems. Viroporins, which can be incorporated in or excluded from the virion, are important for the infectivity of many diverse viruses (reviewed in 104). For the majority of viroporins, the relationship between in vitro pore formation and in vivo ion channel activity has not been firmly established, and the importance of ion conduction in the viral life cycle is not clear.

A strict correlation between ion channel activity and an in vivo mechanism of action has, however, been demonstrated for the influenza A virus viroporin, M2 (reviewed in 104, 105, 106). M2 is a homotetrameric integral membrane protein that is present in the virus envelope in small amounts. The ability of M2 to selectively conduct protons in a low-pH-activated manner has been demonstrated in planar lipid bilayers, amphibian oocytes, and mammalian cells; a specific inhibitor of in vitro ion conductance, amantadine, blocks influenza A virus growth, with resistance mutations mapping to M2105,106. The M2 protein has dual functions in promoting influenza A virus infectivity. During virus egress, intracellular M2 increases the pH of the Golgi lumen, preventing premature activation of the HA envelope protein. During virus entry, M2 in the virion acidifies the particle interior to facilitate genome uncoating. This concordance of evidence has established that ion conduction by M2 is essential for influenza A virus propagation105, 106.

In contrast, the HIV-1 viroporin Vpu does not seem to invoke an in vivo ion channel activity. Vpu is an integral membrane protein that is excluded from virus particles and accomplishes two distinct roles in HIV-1 infectivity by interactions with host factors (reviewed in 104, 105, 107). Vpu binding to intracellular CD4 targets the virus receptor for degradation. This allows free passage of the envelope precursor, gp160, to the sites of budding, as well as favours virus dissemination to naïve cells. In a recently defined independent role, Vpu colocalizes with and antagonizes tetherin, an antiviral host protein that prevents release of nascent particles from the cell surface108.

Viroporins have been reported for many other virus families, including Flaviviridae (p7), Coronaviridae (E), Picornaviridae (2B), and Togaviridae (6K); their roles include virus assembly, budding, and egress (reviewed in 104, 109). It is not known whether these viroporins function by conducting ions, by interacting with host proteins, or by additional undefined mechanisms. As more is uncovered about the roles of small hydrophobic proteins in virus assembly and infectivity, the focus will likely shift from their similar behaviour in vitro to their diverse mechanisms in vivo, and the classification of viroporin may diverge into functionally defined subsets.

By analogy to the influenza A virus viroporin M2, an ion channel activity might protect fusogenic glycoproteins in progeny virions from low-pH mediated inactivation during their passage though the Golgi44. Although HCV and pestivirus particles transit the low-pH compartments of the secretory pathway, the finding that these virions are acid-resistant until post-release priming suggests that such protection may be unnecessary27,28. Deletion of p7 from either BVDV or HCV blocks an early event in virus assembly, before the formation of infectious intracellular particles34,39,40, while mutations in the HCV p7 cytosolic loop seem to decrease virion release40. This small protein might therefore influence several steps of infectious virus production; indeed multiple roles have been reported for other viroporins. As with the majority of viroporins, it is still unclear how the ion channel and oligomerization properties of p7 relate to its functions in progeny virus assembly and release.

NS2 autoprotease

NS2 is a membrane-associated cysteine autoprotease that mediates cleavage of its own carboxyl terminus from NS351,52,53,54,55. Homologues of this enzyme are present in hepaciviruses and pestiviruses, but not flaviviruses. After liberation of NS3, NS2 is dispensable for RNA replication7,8,32,53,56, but is essential for progeny particle production (Fig 4)39,57,58. HCV NS2 functions early in morphogenesis, before the assembly of an infectious intracellular virus39. This function requires at least the protease domain of NS2, but not its catalytic activity, nor the presence of the uncleaved NS2-3 precursor39. In contrast, pestivirus NS2 functions only within the context of uncleaved NS2-357,58; the post-cleavage form of NS2 does not appear to play any role for pestivirus growth in cell culture58. The function of pestivirus uncleaved NS2-3 in morphogenesis does not require the protease activity of NS2, nor the protease, helicase, or NTPase activities of NS3, although cleavage of NS3 from its cofactor, NS4A, is necessary57,58.

While the catalytic activities of NS2 and uncleaved NS2-3 are not required for infectious particle production, these enzymes, or the cleavages that they perform, are essential for replication. This dichotomy suggests that regulated expression or activation of these nonstructural proteins might allow switching from RNA synthesis to virion production, a hypothesis illustrated by pestivirus growth53. BVDV NS2-3 cleavage, and thus RNA replication, is absolutely dependent on a cellular cofactor termed J-domain protein interacting with viral protein (Jiv)59,60. A single molecule of Jiv binds two sites on NS2, one encompassing the catalytic center and the other close to the substrate region, likely positioning these elements to facilitate processing59,61. After cleavage, NS2 remains bound to Jiv, leading to gradual depletion of this limiting co-factor and eventually preventing further rounds of NS2-3 processing59. Titration of Jiv therefore results in the accumulation of uncleaved NS2-3, a plateau of RNA replication, and the commencement of infectious virus production53. Interestingly, this regulation of NS2-3 processing is also linked to the ability of BVDV to establish persistent infection. While coordination of RNA replication and virus assembly through NS2-3 cleavage does not seem to occur during HCV growth in cell culture, controlled processing might impact chronic infection in vivo.

There is evidence that the function of HCV NS2 in infectious progeny assembly requires additional nonstructural proteins. Studies of chimeric genomes encoding sequences from diverse HCV isolates indicated that regions of compatibility within NS2 are major determinants of infectious titre62,63. Specifically, genotypic matching of the amino terminal helix of NS2, p7, and the structural proteins, coupled with pairing of the remainder of NS2 and the replicase proteins led to optimal infectivity62,63. These results hint that NS2 might form multiple functional associations, including interactions with p7, as well as possible independent connections with replicase proteins, such as NS362,63. Indeed, physical interactions between HCV NS2 and NS3 have been reported64. Concerted action of NS2 and NS3 might therefore be a common feature of hepacivirus and pestivirus progeny morphogenesis, with possible physical association of the two HCV proteins and a requirement for the pestivirus uncleaved NS2–3 precursor.


The viruses of the genus Flavivirus do not encode an autoprotease equivalent to NS2. Instead, two hydrophobic proteins that span the membrane several times are encoded upstream of NS3 in the polyprotein. One of these, NS2B, is the NS3 protease cofactor1, the other, NS2A, is an essential component of the replicase (Fig 4)65. Processing within the NS2A-2B-3 region is carried out by the viral protease, NS3, with its NS2B cofactor. NS2A is also cleaved by the viral protease at a cryptic internal site, creating a truncated form of the protein termed NS2Aα66. Mutational analysis revealed that NS2Aα itself is dispensable for replication and infectivity, but that a basic residue at the cleavage site (K190) is essential for production of infectious YFV67. Mutation of K190 did not affect subviral particle secretion, suggesting that NS2A plays an important role in the incorporation of genomic RNA into the budding virion67. Residues in NS2A (I59 and T149) have also been implicated in the production of infectious Kunjin virus (KUN)68,69.

NS2A interacts with other nonstructural proteins, including NS370. Interestingly, second-site changes in the helicase domain of NS3 were found to suppress the assembly defect caused by mutation of the NS2Aα cleavage site67. These findings suggest that, similar to HCV and the pestiviruses, physical associations between the multifunctional NS3 enzyme and an upstream membrane associated protein are essential for infectious flavivirus morphogenesis. Unlike HCV NS2 and pestivirus uncleaved NS2-3, which are not required for RNA replication, NS2A colocalizes with replication complexes70 and has an essential, but poorly understood, role in the process of RNA accumulation65. Purified NS2A binds RNA, leading to the hypothesis that this integral membrane protein might shuttle genomic substrates out of membrane bound replication complexes to the sites of packaging68,70.

NS3 multifunctional enzyme

To date, the only clearly understood mechanism of action for a nonstructural protein in Flaviviridae progeny virus production is the proteolytic role of the NS3 protease from the genus Flavivirus (Fig 4). This enzyme, together with the NS2B cofactor, mediates cleavage of the flavivirus C protein from its membrane anchor, and is therefore essential for maturation of a major virion component. Processing of C on the cytosolic side of the ER membrane by the flaviviral protease is essential for subsequent cleavage of C from the envelope protein, prM, by the host enzyme signal peptidase in the ER lumen71,72. This regulated sequence of cleavages ensures that processing of prM from the polyprotein is delayed, and budding is stalled, until genomic RNA substrates accumulate through replication; the secretion of the flavivirus glycoproteins, E and prM, as immunogenic subviral particles is thereby minimized71,72,73. Inspection of C protein sequences from the genera Pestivirus and Hepacivirus revealed the presence of conserved NS3 protease recognition sites in the corresponding membrane anchors57,74. Subsequently, however, it was found that a host enzyme, signal peptide peptidase, processed both proteins75,76. Although NS3 might interact with C without initiating proteolysis, studies of HCV have shown that mutation of the putative cleavage site residues in C does not drastically affect virus titres77. It is not known if other mechanisms delay budding for these viruses.

While a proteolytic role for NS3 in assembly might be unique to flaviviruses, the discovery of an essential function for pestivirus uncleaved NS2-3 that is independent of its known enzymatic activities, suggested analogous additional roles for NS3 proteins of the Flavivirus and Hepacivirus genera57,58. This hypothesis was supported by the finding that NS3 of the flavivirus, KUN, can function in trans for C processing and RNA replication, but must be supplied in cis for infectious virus to be produced78,79. YFV NS3, which is not absolutely required in cis80, was recently directly implicated in flavivirus morphogenesis81. A single tryptophan residue in the helicase domain is dispensable for RNA replication but essential for nucleocapsid incorporation and possibly other aspects of particle specific infectivity81. By complementation in trans, this function of NS3 in infectious virus assembly was shown to be independent of its protease, helicase and NTPase activities81. NS3 has also been implicated in the production of HCV progeny, as adaptive mutations in this region have been found to augment infectious titres of viruses passaged in cell culture63,82. For a minimally infectious intergenotypic chimaera, titres were specifically increased by the emergence of a point mutation in the NS3 helicase domain63. This mutation rescued infectious virus production without affecting RNA replication, or the known catalytic activities of NS3 (M. Yi and S. Lemon, personal communication).

Protease cofactor

Cofactors NS4A and NS2B (flavivirus) contribute to the structure of NS3, anchor the enzyme to the membrane, are required for the majority of NS3-mediated processing events, and can modulate its helicase activity (reviewed in 1). Although the known enzymatic activities of NS3 are not required for infectious pestivirus production, the presence of the NS4A cofactor significantly increases the activity of the essential precursor, uncleaved NS2-3, in this process (Fig 4)57,58. NS4A can be functionally supplied in trans to uncleaved NS2-3, but it cannot be recruited from an active replication complex, and fragments or full-length NS4A sequences that cannot be cleaved from the NS2-3 precursor are highly inhibitory to its function57,58. This requirement for available NS4A might indicate that a specific conformation of the NS3 protease is essential for the function of uncleaved NS2-3 in virion morphogenesis. Alternatively, NS4A could bind and recruit additional essential factors to the sites of assembly58. The flavivirus protease cofactor, NS2B, is also involved in infectious virus production by facilitating NS3-mediated cleavage of C71,72. Additional functions of NS3 in assembly and infectivity, however, do not require cis-encoded NS2B81. It remains to be tested whether the emerging role for HCV NS3 in progeny virus production will include a requirement for NS4A.

NS5A phosphoprotein

The zinc-binding NS5A proteins of HCV and the pestiviruses83,84 have essential but undefined roles in RNA replication; no enzymatic activity has been ascribed to them (Fig 5). For both genera, these proteins are basally phosphorylated on serines by what seems to be the same cellular kinase(s)85,86; HCV NS5A is also a substrate for casein kinase I (CKI)-α-mediated hyperphosphorylation85,87. A regulatory role for NS5A phosphorylation has long been suspected, and was supported by observations that adaptive mutations7, engineered mutations88, or kinase inhibitors89 that decrease hyperphosphorylation increase RNA replication but abolish HCV infectivity in chimpanzees90. The finding that hyperphosphorylation inhibited the ability of NS5A to bind an essential cellular component of the replicase, hVAP-A, suggested that this modification might serve as a switch to break apart the replication complex and allow infectious virus assembly to begin91,92.

Fig 5
Required features of the NS5A-5B or NS5 regions

Recently, it has been proposed that HCV infectious particle assembly takes place at membrane-associated lipid droplets. These are fatty intracellular deposits at which active replication complexes and envelope proteins congregate in a C-dependent manner93. Mutations within the amino-terminal domain of NS5A (residues 99–104) were found to impair recruitment of the replicase to lipid droplets, while deletions in the carboxy-terminal region of NS5A disrupted its colocalization with C on these structures 94; both types of mutations decreased virus titres, suggesting a direct role for NS5A in infectious virus production93,94. An independent mutational analysis of NS5A identified a single residue (S457) that is dispensable for RNA replication but essential for infectious particle assembly95. Substitution of this serine with alanine abolished infectious titres, while mutation to aspartic acid, which mimicks phosphorylation, rescued the production of progeny virus95. The aspartic acid mutant, but not the wild-type genome, produced normal levels of infectious virus in the presence of casein kinase II (CKII) inhibitors95. This evidence, along with the finding that the serine to aspartic acid change slightly decreased RNA replication, suggested that CKII-dependent phosphorylation of NS5A S457 might mediate a switch between replication and assembly. Although it is not clear whether this serine is part of the basal or hyperphosphorylated subsets, mutations at this position seemed to reduce hyperphosphorylation95. These studies provide compelling evidence that NS5A is a central regulator of virion morphogenesis. Temporally regulated phosphorylation of this protein might influence the localization of replication complexes or impact the partitioning of nascent positive-strand RNA molecules between the competing fates of translation, replication, and encapsidation. Modification of NS5A might also disrupt the replicase machinery, thereby releasing genomes for infectious virus formation.

RNA-dependent RNA polymerase

The flavivirus genome does not encode a homologue of NS5A; its NS5 protein has RNA-dependent RNA polymerase (RdRp) and methyltransferase activities, which are important for RNA synthesis and genome capping respectively (Fig 5). Despite no sequence similarity to NS5A, NS5 has a zinc-binding motif96 and is phosphorylated by a putative NS5A-kinase86, suggesting functional homology between these proteins86. Evidence that DEN NS5 localizes and interacts with NS3 only when hypophosphorylated implies that this protein might also mediate a phosphorylation-dependent relocalization, or disruption, of the replicase complex97. Studies of KUN have revealed that the polymerase activity of NS5 is a prerequisite for assembly, since replication-incompetent genomes were not substrates for incorporation into virions98. Pestivirus and hepacivirus RdRp activity is encoded in NS5B. Although it is not known if these genomes must replicate in order to be packaged, BVDV NS5B has been directly implicated in morphogenesis. Insertion of an epitope tag in the carboxy-terminal region of the polymerase was found to abolish infectious virus production while not affecting RNA replication99.

These data suggest that NS5A, NS5B, and NS5 (flaviviruses) might be central to the regulation and coupling of RNA synthesis and virion morphogenesis, a link that likely depends on physical connections between membranous sites of replication and assembly93,98. Immuno-electronmicroscopy of KUN-infected cells has visualized flavivirus structural proteins at modified membranes proximal to vesicle packets that are thought to be the sites of RNA replication100. Similar membranous structures have been observed in pestivirus-infected, as well as in HCV-infected cells3,4. HCV replication and assembly seem to converge at lipid droplets93, a unique adaptation that may position budding particles for egress in association with VLDL. Hepatocytes are among the few cell types that secrete lipoproteins, suggesting that utilization of this pathway may dictate the highly restricted tropism of this virus31. Coupling of replication and virion formation at membranous intracellular structures might be envisioned to limit the propagation of defective genomes, and may be essential in the context of the highly error-prone RdRp activities98. Direct transfer of RNA from an active replication complex to an assembling particle might also provide a mechanism for specific genome encapsidation in the absence of a packaging signal94.

Nonstructural proteins and structural proteins

Nonstructural factors might be expected to form transient physical interactions with virion components in order to orchestrate their assembly, indeed it is possible that replicase proteins are incorporated into virus particles at levels below the current limits of detection. Flavivirus NS3 is known to interact with C, as it cleaves the hydrophobic anchor from this structural protein72. Passaging of assembly-defective HCV genomes has revealed multiple genetic interactions between structural and nonstructural sequences. Intergenotypic incompatibility of the C-NS2 region with the replicase proteins could be overcome by a compensatory mutation in E1 that acts synergistically with changes in NS2 or NS363, while genomes with deleterious mutations in C were rescued to various degrees by emergent mutations in p7, NS2 and NS382. Evidence for physical interactions between NS2 and E2101, as well as NS5A and C102, has also been uncovered. The functional cooperation between NS5A and C in the recruitment of structural and replicase components to lipid droplets as a prerequisite for infectious HCV assembly has emphasized the importance of these associations93.


While the formation of an infectious virus certainly requires concerted action by the structural proteins, evidence highlighted here underscores the importance of nonstructural proteins in this complex process. All Flaviviridae seem to share some common requirements for infectious virus production: coordination of the multifunctional NS3 protein with upstream hydrophobic sequences, and the coupling of replication to assembly through the functions of a replicase phosphoprotein and the RdRp. Nonstructural proteins that are involved in these processes might mediate localization of active replication complexes to specialized sites of assembly, regulate the release of RNA from the replicase, or ensure genome incorporation into a budding particle. Additional nonstructural proteins that are absent from the flavivirus genome might address unique requirements of HCV and pestivirus morphogenesis. The apparently coordinated roles of p7 and NS2 could participate in the initiation of virion assembly, mediate glycoprotein organization and budding, or ensure particle maturation, processes that may have diverged mechanistically from the flaviviruses.

Once thought to function solely in the accumulation of viral RNA, Flaviviridae nonstructural proteins are now emerging as integral players in the process of virion morphogenesis. With almost every nonstructural protein now implicated in progeny virus production, much work remains in assigning their specific roles and elucidating their mechanisms of action. Ultimately it may be possible to exploit these essential functions in the development of antiviral drugs to treat the devastating infections caused by this group of viruses.

Table 1
Flaviviridae nonstructural proteins involved in virion morphogenesis


We thank Timothy Tellinghuisen, Richard Kuhn, Chinmay Patkar, Stanley Lemon, and MinKyung Yi for sharing pre-publication results. We acknowledge Timothy Tellinghuisen for critical reading of the manuscript. Work on infectious virus assembly in CMR’s laboratory is supported by PHS grants (CA057973, AI072613, AI075099), the Starr Foundation, and the Greenberg Medical Research Institute.


1. Lindenbach BD, Thiel HJ, Rice CM. In: Fields Virology. Knipe DM, Howley PM, editors. Lippincott-Raven Publishers; Philadelphia: 2007. pp. 1101–1152.
2. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus- induced membrane structures. J Virol. 1997;71:6650–61. [PMC free article] [PubMed]
3. Gray EW, Nettleton PF. The ultrastructure of cell cultures infected with border disease and bovine virus diarrhoea viruses. J Gen Virol. 1987;68:2339–2346. [PubMed]
4. Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Torrisi MR, Pedrazzini E, Bonatti S, Migliaccio G. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology. 2002;293:31–43. [PubMed]
5. Meyers G, Tautz N, Becher P, Thiel HJ, Kümmerer BM. Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. J Virol. 1996;70:8606–8613. [PMC free article] [PubMed]
6. Rice CM, Grakoui A, Galler R, Chambers TJ. Transcription of infectious yellow fever virus RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1989;1:285–296. [PubMed]
7. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science. 2000;290:1972–1974. [PubMed]
8. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285:110–113. [PubMed]
9. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. Complete replication of hepatitis C virus in cell culture. Science. 2005;309:623–6. [PubMed]
10. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005;11:791–6. [PMC free article] [PubMed]
11. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2005;102:9294–9. [PMC free article] [PubMed]
12. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108:717–25. [PMC free article] [PubMed]
13. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. Structure of West Nile virus. Science. 2003;302:248. [PubMed]
14. Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol. 2003;10:907–12. [PMC free article] [PubMed]
15. Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak D, Baker TS, Strauss JH, Kuhn RJ, Rossmann MG. Structures of immature flavivirus particles. Embo J. 2003;22:2604–13. [PMC free article] [PubMed]
16. Zhang Y, Kostyuchenko VA, Rossmann MG. Structural analysis of viral nucleocapsids by subtraction of partial projections. J Struct Biol. 2007;157:356–64. [PMC free article] [PubMed]
17. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci U S A. 2004;101:3414–9. [PMC free article] [PubMed]
18. Dokland T, Walsh M, Mackenzie JM, Khromykh AA, Ee KH, Wang S. West Nile virus core protein; tetramer structure and ribbon formation. Structure. 2004;12:1157–63. [PubMed]
19. Ferlenghi I, Clarke M, Ruttan T, Allison SL, Schalich J, Heinz FX, Harrison SC, Rey FA, Fuller SD. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell. 2001;7:593–602. [PubMed]
20. Konishi E, Pincus S, Fonseca BA, Shope RE, Paoletti E, Mason PW. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology. 1991;185:401–10. [PubMed]
21. Zhang Y, Kaufmann B, Chipman PR, Kuhn RJ, Rossmann MG. Structure of immature West Nile virus. J Virol. 2007;81:6141–5. [PMC free article] [PubMed]
22. Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, Chipman PR, Kuhn RJ, Rossmann MG, Chen J. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science. 2008;319:1834–7. [PubMed]
23. Stadler K, Allison SL, Schalich J, Heinz FX. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol. 1997;71:8475–8481. [PMC free article] [PubMed]
24. Heinz FX, Stiasny K, Puschner-Auer G, Holzmann H, Allison SL, Mandl CW, Kunz C. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology. 1994;198:109–17. [PubMed]
25. Gastaminza P, Kapadia SB, Chisari FV. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol. 2006;80:11074–81. [PMC free article] [PubMed]
26. Macovei A, Zitzmann N, Lazar C, Dwek RA, Branza-Nichita N. Brefeldin A inhibits pestivirus release from infected cells, without affecting its assembly and infectivity. Biochem Biophys Res Commun. 2006;346:1083–90. [PubMed]
27. Krey T, Thiel HJ, Rumenapf T. Acid-resistant bovine pestivirus requires activation for pH-triggered fusion during entry. J Virol. 2005;79:4191–200. [PMC free article] [PubMed]
28. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol. 2006;80:1734–41. [PMC free article] [PubMed]
29. Chang KS, Jiang J, Cai Z, Luo G. Human apolipoprotein E is required for Infectivity and Production of Hepatitis C Virus in Cell Culture. J Virol. 2007 [PMC free article] [PubMed]
30. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV. Cellular determinants of hepatitis C virus assembly, maturation, degradation and secretion. J Virol. 2007 [PMC free article] [PubMed]
31. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, Jr, Ye J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A. 2007;104:5848–53. [PMC free article] [PubMed]
32. Behrens SE, Grassmann CW, Thiel HJ, Meyers G, Tautz N. Characterization of an autonomous subgenomic pestivirus RNA replicon. J Virol. 1998;72:2364–72. [PMC free article] [PubMed]
33. Khromykh AA, Kenney MT, Westaway EG. trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J Virol. 1998;72:7270–9. [PMC free article] [PubMed]
34. Harada T, Tautz N, Thiel HJ. E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies. J Virol. 2000;74:9498–506. [PMC free article] [PubMed]
35. Carrere-Kremer S, Montpellier-Pala C, Cocquerel L, Wychowski C, Penin F, Dubuisson J. Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus. J Virol. 2002;76:3720–30. [PMC free article] [PubMed]
36. Elbers K, Tautz N, Becher P, Stoll D, Rumenapf T, Thiel HJ. Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7. J Virol. 1996;70:4131–5. [PMC free article] [PubMed]
37. Lin C, Lindenbach BD, Prágai B, McCourt DW, Rice CM. Processing of the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J Virol. 1994;68:5063–5073. [PMC free article] [PubMed]
38. Mizushima H, Hijikata H, Asabe SI, Hirota M, Kimura K, Shimotohno K. Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol. 1994;68:6215–6222. [PMC free article] [PubMed]
39. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol. 2007;81:8374–83. [PMC free article] [PubMed]
40. Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T. Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions. PLoS Pathog. 2007;3:e103. [PMC free article] [PubMed]
41. Carrere-Kremer S, Montpellier C, Lorenzo L, Brulin B, Cocquerel L, Belouzard S, Penin F, Dubuisson J. Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions. J Biol Chem. 2004;279:41384–92. [PubMed]
42. Isherwood BJ, Patel AH. Analysis of the processing and transmembrane topology of the E2p7 protein of hepatitis C virus. J Gen Virol. 2005;86:667–76. [PubMed]
43. Griffin SD, Beales LP, Clarke DS, Worsfold O, Evans SD, Jaeger J, Harris MP, Rowlands DJ. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 2003;535:34–8. [PubMed]
44. Griffin SD, Harvey R, Clarke DS, Barclay WS, Harris M, Rowlands DJ. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol. 2004;85:451–61. [PubMed]
45. Pavlovic D, Neville DC, Argaud O, Blumberg B, Dwek RA, Fischer WB, Zitzmann N. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci U S A. 2003;100:6104–8. [PMC free article] [PubMed]
46. StGelais C, Tuthill TJ, Clarke DS, Rowlands DJ, Harris M, Griffin S. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system. Antiviral Res. 2007;76:48–58. [PubMed]
47. Patargias G, Zitzmann N, Dwek R, Fischer WB. Protein-protein interactions: modeling the hepatitis C virus ion channel p7. J Med Chem. 2006;49:648–55. [PubMed]
48. Clarke D, Griffin S, Beales L, Gelais CS, Burgess S, Harris M, Rowlands D. Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J Biol Chem. 2006;281:37057–68. [PubMed]
49. Premkumar A, Wilson L, Ewart GD, Gage PW. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett. 2004;557:99–103. [PubMed]
50. Sakai A, Claire MS, Faulk K, Govindarajan S, Emerson SU, Purcell RH, Bukh J. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci U S A. 2003;100:11646–51. [PMC free article] [PubMed]
51. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA. 1993;90:10583–10587. [PMC free article] [PubMed]
52. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993;67:4665–4675. [PMC free article] [PubMed]
53. Lackner T, Muller A, Pankraz A, Becher P, Thiel HJ, Gorbalenya AE, Tautz N. Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus. J Virol. 2004;78:10765–75. [PMC free article] [PubMed]
54. Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature. 2006;442:831–5. [PubMed]
55. Santolini E, Pacini L, Fipaldini C, Migliaccio G, Monica N. The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol. 1995;69:7461–7471. [PMC free article] [PubMed]
56. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science. 1997;277:570–574. [PubMed]
57. Agapov EV, Murray CL, Frolov I, Qu L, Myers TM, Rice CM. Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea virus. J Virol. 2004;78:2414–25. [PMC free article] [PubMed]
58. Moulin HR, Seuberlich T, Bauhofer O, Bennett LC, Tratschin JD, Hofmann MA, Ruggli N. Nonstructural proteins NS2-3 and NS4A of classical swine fever virus: essential features for infectious particle formation. Virology. 2007;365:376–89. [PubMed]
59. Lackner T, Muller A, Konig M, Thiel HJ, Tautz N. Persistence of bovine viral diarrhea virus is determined by a cellular cofactor of a viral autoprotease. J Virol. 2005;79:9746–55. [PMC free article] [PubMed]
60. Rinck G, Birghan C, Harada T, Meyers G, Thiel HJ, Tautz N. A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus. J Virol. 2001;75:9470–82. [PMC free article] [PubMed]
61. Lackner T, Thiel HJ, Tautz N. Dissection of a viral autoprotease elucidates a function of a cellular chaperone in proteolysis. Proc Natl Acad Sci U S A. 2006;103:1510–5. [PMC free article] [PubMed]
62. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A. 2006;103:7408–13. [PMC free article] [PubMed]
63. Yi M, Ma Y, Yates J, Lemon SM. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol. 2007;81:629–38. [PMC free article] [PubMed]
64. Kiiver K, Merits A, Ustav M, Zusinaite E. Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res. 2006;117:264–72. [PubMed]
65. Khromykh AA, Sedlak PL, Westaway EG. cis- and trans-acting elements in flavivirus RNA replication. J Virol. 2000;74:3253–63. [PMC free article] [PubMed]
66. Nestorowicz A, Chambers TJ, Rice CM. Mutagenesis of the yellow fever virus NS2A/2B cleavage site: Effects on proteolytic processing, viral replication and evidence for alternative processing of the NS2A protein. Virology. 1994;199:114–123. [PubMed]
67. Kümmerer B, Rice CM. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious virus. J Virol. 2002;76:4773–84. [PMC free article] [PubMed]
68. Liu WJ, Chen HB, Khromykh AA. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol. 2003;77:7804–13. [PMC free article] [PubMed]
69. Leung JY, Pijlman GP, Kondratieva N, Hyde J, Mackenzie JM, Khromykh AA. The Role of Nonstructural Protein Ns2a in Flavivirus Assembly. J Virol. 2008 [PMC free article] [PubMed]
70. Mackenzie JM, Khromykh AA, Jones MK, Westaway EG. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology. 1998;245:203–15. [PubMed]
71. Amberg SM, Nestorowicz A, McCourt DW, Rice CM. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J Virol. 1994;68:3794–3802. [PMC free article] [PubMed]
72. Lobigs M. Flavivirus premembrane protein cleavage and spike heterodimer secretion requires the function of the viral proteinase NS3. Proc Natl Acad Sci USA. 1993;90:6218–6222. [PMC free article] [PubMed]
73. Lobigs M, Lee E. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J Virol. 2004;78:178–86. [PMC free article] [PubMed]
74. Santolini E, Migliaccio G, La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 1994;68:3631–3641. [PMC free article] [PubMed]
75. Heimann M, Roman-Sosa G, Martoglio B, Thiel HJ, Rumenapf T. Core protein of pestiviruses is processed at the C terminus by signal peptide peptidase. J Virol. 2006;80:1915–21. [PMC free article] [PubMed]
76. McLauchlan J, Lemberg MK, Hope G, Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO Journal. 2002;21:3980–8. [PMC free article] [PubMed]
77. Shavinskaya A, Boulant S, Penin F, McLauchlan J, Bartenschlager R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem. 2007 [PubMed]
78. Liu WJ, Sedlak PL, Kondratieva N, Khromykh AA. Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly. J Virol. 2002;76:10766–75. [PMC free article] [PubMed]
79. Pijlman GP, Kondratieva N, Khromykh AA. Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging. J Virol. 2006;80:11255–64. [PMC free article] [PubMed]
80. Jones CT, Patkar CG, Kuhn RJ. Construction and applications of yellow fever virus replicons. Virology. 2005;331:247–59. [PubMed]
81. Patkar CG, Kuhn RJ. Yellow Fever Virus NS3 Plays an Essential Role in Virus Assembly Independent of Its Known Enzymatic Functions. J Virol. 2008 [PMC free article] [PubMed]
82. Murray CL, Jones CT, Tassello J, Rice CM. Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol. 2007;81:10220–31. [PMC free article] [PubMed]
83. Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem. 2004 [PubMed]
84. Tellinghuisen TL, Paulson MS, Rice CM. The NS5A protein of bovine viral diarrhea virus contains an essential zinc-binding site similar to that of the hepatitis C virus NS5A protein. J Virol. 2006;80:7450–8. [PMC free article] [PubMed]
85. Tanji Y, Kaneko T, Satoh S, Shimotohno K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol. 1995;69:3980–3986. [PMC free article] [PubMed]
86. Reed KE, Gorbalenya AE, Rice CM. The NS5A/NS5 proteins of viruses from three genera of the family Flaviviridae are phosphorylated by associated serine/threonine kinases. J Virol. 1998;72:6199–6206. [PMC free article] [PubMed]
87. Quintavalle M, Sambucini S, Summa V, Orsatti L, Talamo F, De Francesco R, Neddermann P. Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors. J Biol Chem. 2007;282:5536–44. [PubMed]
88. Appel N, Pietschmann T, Bartenschlager R. Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol. 2005;79:3187–94. [PMC free article] [PubMed]
89. Neddermann P, Quintavalle M, Di Pietro C, Clementi A, Cerretani M, Altamura S, Bartholomew L, De Francesco R. Reduction of Hepatitis C Virus NS5A Hyperphosphorylation by Selective Inhibition of Cellular Kinases Activates Viral RNA Replication in Cell Culture. J Virol. 2004;78:13306–14. [PMC free article] [PubMed]
90. Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A. 2002;99:14416–21. [PMC free article] [PubMed]
91. Gao L, Aizaki H, He JW, Lai MM. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol. 2004;78:3480–8. [PMC free article] [PubMed]
92. Evans MJ, Rice CM, Goff SP. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A. 2004;101:13038–43. [PMC free article] [PubMed]
93. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol. 2007;9:1089–97. [PubMed]
94. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008;4:e1000035. [PMC free article] [PubMed]
95. Tellinghuisen TL, Foss KL, Treadaway J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog. 2008;4:e1000032. [PMC free article] [PubMed]
96. Yap TL, Xu T, Chen YL, Malet H, Egloff MP, Canard B, Vasudevan SG, Lescar J. Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol. 2007;81:4753–65. [PMC free article] [PubMed]
97. Kapoor M, Zhang L, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R. Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J Biol Chem. 1995;270:19100–19106. [PubMed]
98. Khromykh AA, Varnavski AN, Sedlak PL, Westaway EG. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J Virol. 2001;75:4633–40. [PMC free article] [PubMed]
99. Ansari IH, Chen LM, Liang D, Gil LH, Zhong W, Donis RO. Involvement of a bovine viral diarrhea virus NS5B locus in virion assembly. J Virol. 2004;78:9612–23. [PMC free article] [PubMed]
100. Mackenzie JM, Westaway EG. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol. 2001;75:10787–99. [PMC free article] [PubMed]
101. Selby MJ, Glazer E, Masiarz F, Houghton M. Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology. 1994;204:114–122. [PubMed]
102. Goh PY, Tan YJ, Lim SP, Lim SG, Tan YH, Hong WJ. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology. 2001;290:224–36. [PubMed]
103. Tellinghuisen TL, Foss KL, Treadaway JC, Rice CM. Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J Virol. 2008;82:1073–83. [PMC free article] [PubMed]
104. Gonzalez ME, Carrasco L. Viroporins. FEBS Lett. 2003;552:28–34. [PubMed]
105. Lamb RA, Pinto LH. Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles? Virology. 1997;229:1–11. [PubMed]
106. Kelly ML, Cook JA, Brown-Augsburger P, Heinz BA, Smith MC, Pinto LH. Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS Lett. 2003;552:61–7. [PubMed]
107. Strebel K. HIV accessory genes Vif and Vpu. Adv Pharmacol. 2007;55:199–232. [PubMed]
108. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008;451:425–30. [PubMed]
109. Liu DX, Yuan Q, Liao Y. Coronavirus envelope protein: a small membrane protein with multiple functions. Cell Mol Life Sci. 2007;64:2043–8. [PubMed]
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...